US Health Care Reform and Transplantation, Part II: Impact on the Public Sector and Novel Health Care Delivery Systems

被引:30
作者
Axelrod, D. A. [1 ]
Millman, D. [2 ]
Abecassis, M. M. [3 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA
[2] Powers Pyles Sutter & Verville PC, Washington, DC USA
[3] NW Mem Hosp, Dept Surg, Chicago, IL 60611 USA
关键词
Comparative effectiveness; health economics; insurance; regulation; OVERSIGHT; MEDICARE;
D O I
10.1111/j.1600-6143.2010.03247.x
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
The Patient Protection and Affordable Care Act passed in 2010 will result in dramatic expansion of publically funded health insurance coverage for low-income individuals. It is estimated that of the 32 million newly insured, 16 million will obtain coverage through expansion of the Medicaid Program, and the remaining 16 million will purchase coverage through their employer or newly legislated insurance exchanges. While the Act contains numerous provisions to improve access to private insurance as discussed in Part I of this analysis, public sector coverage will significantly be affected. The cost of health care reform will be borne disproportionately by Medicare, which faces nearly $500 billion in cuts to be identified by a new independent board. Transplant centers should be concerned about the impact of the reform on the financial aspects of transplantation. In addition, this legislation also utilizes the Medicare Program to drive reform of the health care delivery system, by encouraging the development of integrated Accountable Care Organizations, experimentation with new 'models' of health care delivery, and expanded support for Comparative Effectiveness Research. Transplant providers, including transplant centers and physicians/surgeons need to lead this movement, drawing on our experience providing comprehensive multidisciplinary care under global budgets with publically reported outcomes.
引用
收藏
页码:2203 / 2207
页数:5
相关论文
共 8 条
[1]
Organ transplant programs: Federal agencies have acted to improve oversight, but implementation issues remain [J].
Abecassis, M. M. ;
Burke, R. ;
Cosimi, A. B. ;
Matas, A. J. ;
Merion, R. M. ;
Millman, D. ;
Roberts, J. P. ;
Klintmalm, G. B. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (12) :2496-2502
[2]
American Society of Transplant Surgeons Transplant Center Outcomes Requirements-A Threat to Innovation [J].
Abecassis, M. M. ;
Burke, R. ;
Klintmalm, G. B. ;
Matas, A. J. ;
Merion, R. M. ;
Millman, D. ;
Olthoff, K. ;
Roberts, J. P. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (06) :1279-1286
[3]
Making Dollars and Sense out of Liver Transplantation [J].
Abecassis, Michael .
LIVER TRANSPLANTATION, 2009, 15 (10) :1159-1161
[4]
Creating accountable care organizations: The extended hospital medical staff [J].
Fisher, Elliott S. ;
Staiger, Douglas O. ;
Bynum, Julie P. W. ;
Gottlieb, Daniel J. .
HEALTH AFFAIRS, 2007, 26 (01) :W44-W57
[5]
Fostering Accountable Health Care: Moving Forward In Medicare [J].
Fisher, Elliott S. ;
McClellan, Mark B. ;
Bertko, John ;
Lieberman, Steven M. ;
Lee, Julie J. ;
Lewis, Julie L. ;
Skinner, Jonathan S. .
HEALTH AFFAIRS, 2009, 28 (02) :W219-W231
[6]
Transplantation Oversight-Finding the Right Balance Between the Layperson, the Transplant Professional and the Regulator [J].
Klintmalm, G. B. G. ;
Abecassis, M. M. I. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (01) :5-6
[7]
Higher Health Care Quality And Bigger Savings Found At Large Multispecialty Medical Groups [J].
Weeks, William B. ;
Gottlieb, Daniel J. ;
Nyweide, David E. ;
Sutherland, Jason M. ;
Bynum, Julie ;
Casalino, Lawrence P. ;
Gillies, Robin R. ;
Shortell, Stephen M. ;
Fisher, Elliott S. .
HEALTH AFFAIRS, 2010, 29 (05) :991-997
[8]
Cost-effectiveness of extending medicare coverage of immunosuppressive medications to the life of a kidney transplant [J].
Yen, EF ;
Hardinger, K ;
Brennan, DC ;
Woodward, RS ;
Desai, NM ;
Crippin, JS ;
Gage, BF ;
Schnitzler, MA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (10) :1703-1708